Phase 1 Trial of SYNC-T - Immunotherapy for Patients With Advanced/Metastatic Solid Tumors

SV-101 is intended to overcome the complex and multifactorial nature of the mechanisms mediating tumor immune evasion, by the use of a combination of therapeutic agents that elicit multiple immuno-pharmacologic effects.

Trial Details

NCT ID
NCT05544240
Phase
PHASE1
Sponsor
Williams Cancer Foundation
Status
RECRUITING
Cancer Type
Breast Cancer
Interventions
  • SV-101
Locations (sample)
  • Mexico City, Mexico|19.42847,-99.12766

Key Eligibility Criteria

  • Male or female, aged \>18 years old at the time of signed informed consent
  • Provide written informed consent and must be willing to adhere with treatment and follow-up.
  • Subjects with advanced and/or metastatic histologically or cytologically confirmed solid tumor who have not responded or progressed after standard …
  • Meet all eligibility criteria

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Breast Cancer Trials on Trialify →